PMS21 COST-EFFECTIVENESS SIMULATION MODEL OF ABATACEPT VERSUS RITUXIMAB IN RHEUMATOID ARTHRITIS IN FRANCE
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66789-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)66789-7/fulltext
Title :
PMS21 COST-EFFECTIVENESS SIMULATION MODEL OF ABATACEPT VERSUS RITUXIMAB IN RHEUMATOID ARTHRITIS IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66789-7&doi=10.1016/S1098-3015(10)66789-7
First page :
Section Title :
Open access? :
No
Section Order :
624